Inactief instrument

Andere talen Biostage Inc Nasdaq

Aandelen

US09074M1036

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Harvard Apparatus Regenerative Technology : Q1 - 2024 HBIO Quarterly Earnings Presentation	07/05
Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding	15/04
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Harvard Apparatus Regenerative Technology : March 19, 2024 - Investor Presentation	18/03
Harvard Apparatus Regenerative Technology : Q4 - 2023 HBIO Quarterly Earnings Presentation	07/03
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Harvard Apparatus Regenerative Technology : Northland Capital Markets Institutional Investor Conference 2023	18-09-23
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Harvard Apparatus Regenerative Technology : Q2 - 2023 HBIO Quarterly Earnings Presentation	08-08-23
Biostage Activated Mayo Clinic as the First Site for Clinical Trial in Severe Esophageal Disease	19-07-23
Biostage, Inc. Activated Mayo Clinic as the First Site for Clinical Trial in Severe Esophageal Disease	18-07-23
Purcell & Lefkowitz LLP Is Investigating Biostage, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors	15-06-23
Biostage to Host Investor Call	13-06-23
Biostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal Disease	31-05-23
Biostage, Inc. Initiates Study Start-Up Activities for Clinical Trial in Severe Esophageal Disease	31-05-23
Biostage Initiates Study Start-Up Activities for Clinical Trial in Severe Esophageal Disease	31-05-23
Biostage, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12-05-23
Biostage, Inc. announced that it has received $6.005802 million in funding	13-04-23
BIOSTAGE, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	10-04-23
Biostage Appoints Ron Packard to Board of Directors	10-04-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biostage Inc Nasdaq

Aandelen

US09074M1036

Andere talen

Filters